04.16.25 -- STREAM Edition: Optimizing Protocols And Selecting Reliable Clinical Endpoints

Ruben, a news anchor from Laredo, Texas, provides a unique perspective as the inaugural participant in a COVID-19 vaccine trial, offering unprecedented insights into his daily experiences and motivations for joining clinical research.

Ensure seamless, accurate global study translations and efficient localization with IQVIA eCOA, leveraging our proven vendor relationships and streamlined process to keep your study on track.

Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

According to Jimmy Bechtel of SCRS, part of the one-and-done PI problem is the financials associated with clinical research.

Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.

Join industry leaders from Anju and 9 Labs for a presentation on the pivotal role of Strategic Communication Plans (SCP) in medical affairs.

Join us for an exclusive discussion that uncovers the science behind our efficient management of key sponsor deliverables and critical milestones, driving our projects to success.

Learn the history behind the Harley Jacobsen Act (H.R. 7418), a bill introduced to Congress in 2024 that seeks to exempt all clinical trial payments from taxation.

In this presentation, industry experts explain the role of PAOs, tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.

Explore how TrialKit's advanced AI capabilities deliver powerful analytics and reporting, setting a new standard for efficiency and innovation in clinical trials.